Ownership

Joseph L. Goldstein - Insider Trading & Ownership

Entity: Individual
Location: Dept Of Pharmacology K5 Yuver Of Texas, 5323 Harry Hines Blvd, Dallas, TX
Summary: The estimated net worth of Joseph L. Goldstein is at least $4.64M dollars as of January 6, 2025. Joseph L. Goldstein is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $4.64M.
All Insider Reports: All Insider Reports

Ownership of Joseph L. Goldstein

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
REGN	REGENERON PHARMACEUTICALS, INC.	Director	$4.64M			Jan 2, 2025

Showing 1 to 1 of 1 entries

Insider Transactions Reported by Joseph L. Goldstein:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Award	+2.6%	$0	0.00	+166	6.55K	1/2/2025	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Award		$0	0.00	+1.96K	1.96K	1/2/2025	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Options Exercise	+42.4%	$1.69M	625.60	+2.71K	9.09K	1/23/2024	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Sale	-29.8%	-$2.57M	950.00	-2.71K	6.38K	1/23/2024	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Options Exercise	-100%	$0	0.00^*	-2.71K	0	1/23/2024	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Award	+2.16%	$0	0.00	+135	6.38K	1/2/2024	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Award		$0	0.00	+1.61K	1.61K	1/2/2024	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Options Exercise	+57.8%	$1.74M	482.68	+3.61K	9.86K	2/6/2023	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Sale	-36.6%	-$2.89M	800.00	-3.61K	6.25K	2/6/2023	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Options Exercise	-100%	$0	0.00^*	-3.61K	0	2/6/2023	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Award	+2.71%	$0	0.00	+165	6.25K	1/3/2023	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Award		$0	0.00	+1.93K	1.93K	1/3/2023	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Sale	-28.6%	-$1.7M	700.00	-2.43K	6.08K	3/30/2022	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Options Exercise	+40%	$909K	374.12	+2.43K	8.51K	3/30/2022	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Options Exercise	-100%	$0	0.00^*	-2.43K	0	3/30/2022	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Award	+3.24%	$0	0.00	+191	6.08K	1/3/2022	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Award		$0	0.00	+2.71K	2.71K	1/3/2022	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Sale	-29.6%	-$1.61M	650.00	-2.48K	5.89K	9/10/2021	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Options Exercise	+42.1%	$944K	380.95	+2.48K	8.37K	9/10/2021	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Options Exercise	-100%	$0	0.00^*	-2.48K	0	9/10/2021	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Options Exercise	+32.8%	$722K	374.12	+1.93K	7.82K	6/7/2021	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Common Stock	Sale	-24.7%	-$1.01M	525.00	-1.93K	5.89K	6/7/2021	Direct
REGN	Regeneron Pharmaceuticals, Inc.	Non-Qualified Stock Option (right to buy)	Options Exercise	-44.3%	$0	0.00	-1.93K	2.43K	6/7/2021	Direct

Previous1Next

Showing 1 to 23 of 23 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.